Filter Results
Filter Results
Mammalian (1) Microbial (2)
Difficult to Express Proteins (1) Fabs, Fusion, Scaffold and other Recombinant Proteins (1)
Clinical Supply Services (1) Commercial Supply Services (3) Ibex® Dedicate (3) IND-to-BLA (1) Manufacturing: cGMP (1) Manufacturing: GMP Drug Product (2) Manufacturing: GMP Drug Substance (1) Process Development and Optimization (1)
Article (1) Webinar (on-demand) (1) White paper (1)
Ibex® DedicateX
Reset Filters
   Loading...
Showing 1‐3 of 3
Article
4 min read
Welcome to the Microbe Factory
We see a growing number of small biotechs that choose to bring their products to the market themselves. In this article we explain how a CDMO can help them navigate clinical CMC hurdles, including bioprocess scale-up and preparing for what may be their fi...
Webinar (on-demand)
Connecting Clinic and Commercial Biopharma Manufacturing
This discussion between Charles Christy, Director of Commercial Solutions for Ibex Dedicate and Anthony Davis from Dark Horse Consulting Group looks at how a new level of visibility for the biopharma manufacturing sector has changed relationships, investm...
White paper
Answering Today's Pharma Dilemma of Build or Buy
The need to increase speed and flexibility in drug development and manufacturing has led to new strategies to improve the development and clinical trial process. It has also led to technological innovations, such as those driving the implementation of con...